-
Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
October 22, 2026 -
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
October 20, 2026 -
Third Quarter 2026 Letter to Shareholders
October 20, 2026
Corporate Overview
Aclarion is a healthcare technology company focused on advancing the care of patients by combining the imaging capabilities of magnetic resonance spectroscopy (MRS) with a proprietary, augmented-intelligence algorithm to noninvasively deliver SaaS solutions that help physicians personalize treatment plans to support improved clinical outcomes and return patients to full, pain-free lives. The company’s first solution will address unmet needs in the low back and neck pain market. To learn more, visit www.aclarion.com.